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INTRODUCTION
This paper describes the methods, feasibility, and early experi-
ence of a statewide, multifaceted quality improvement project 
designed to assess and improve the quality of provider-parent 
communication after newborn screening (NBS) identifies het-
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erozygous (“carrier”) status for cystic 
fibrosis (CF) or sickle cell hemoglobin-
opathy (SCH). 
NBS is a population-scale pub-
lic health program in which newborn 
infants’ blood specimens are applied to 
a special filter paper, dried, and tested 
at a centralized laboratory for a panel 
of genetic and metabolic diseases.1 CF 
and SCH are included on NBS panels 
because the diseases’ risk of death and 
disability can be reduced if the disease 
is identified before becoming symptom-
atic.2-4 
CF is a metabolic disease in which 
abnormal secretions lead to lung disease, 
nutritional problems, and dangerous 
losses of salt in sweat.2 SCH is a blood 
disorder in which a hemoglobin muta-
tion (S) is associated with painful crises, 
life-threatening infections, and vascu-
lopathy, leading to problems like stroke.3 
Both CF and SCH are autosomal 
recessive conditions, and carrier infants are identified in far 
greater numbers than infants with the actual diseases. Infants 
with carrier status for CF and SCH do not develop the actual 
disease, but their children may develop the disease if the other 
parent is also a carrier. Unfortunately, many families of carrier 
infants develop psychosocial complications after NBS, rang-
ing from clinical levels of parental anxiety and depression to 
impaired parent-child bonding and the vulnerable child syn-
drome.5-10 NBS programs have developed materials for edu-
cation and support of families, but first conversations can 
be critical, and the quality of primary care providers’ (PCPs) 
communication about NBS has been criticized by parents and 
NBS officials.11,12 Psychosocial problems after carrier identifica-
tion are cited by bioethicists and others as grounds for delay-
ing or discontinuing some NBS activities.7-9,13,14 To ensure the 
continuation of successful NBS programs and reduce harm 
from psychosocial complications, we developed the Wisconsin 
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test. The most common CF-associated mutation is ΔF508 but 
there are many others.2 The sweat test is done because up to 
2% to 5% of infants with a single mutation have an unmea-
sured second mutation that results in actual CF.2 It has been 
recommended to have the sweat test before 8 weeks of age to 
have the benefit of early identification,4 so the NBS laboratory 
faxes results to PCPs and tracks whether sweat tests have been 
done. The Project uses the term “likely CF carrier” for infants 
who had an elevated immunoreactive trypsinogen and a single 
CF-associated mutation, but who have not yet had a sweat 
chloride test.
Project Design
The Project expands the standard NBS methods for telephone 
follow-up to serve the typical number of about 900 infants 
born each year in Wisconsin with SCH carrier status or likely 
CF carrier status (Figure 1). An initial telephone call is con-
ducted with the infant’s PCP immediately after the abnor-
mal NBS result is found. A second call is conducted with the 
infant’s parents when the infant is between 3 and 5 months 
old, allowing sufficient time for infants to have at least 1 well-
child visit during which the NBS result could be discussed. 
Scripts for telephone calls are similar to those that might be 
used for purely clinical follow-up, but have some additional 
research questions embedded in them. After telephone calls 
to the PCP and parent, an anonymous evaluation survey is 
distributed. The survey’s questions are described in the Results 
section.
Participants
The main participants in the Project are the infants’ parents, 
although data also are collected about the infants and their 
PCPs. 
To reduce confounding effects of other factors that might 
cause potential anxiety or correlate with other psychosocial 
issues, we exclude infants when the NBS report (1) lists more 
than 1 abnormality, (2) states that the gestational age was <35 
weeks, or (3) states that the calendar age at the time of speci-
men collection was >180 days of age. We also exclude infants if 
we discover the infant required either (1) >5 days in a neonatal 
intensive care unit, (2) hospitalization after discharge from the 
nursery, or (3) evaluation for some other medical abnormality. 
During the PCP call, we ask the PCP to identify parents who 
do not speak English and other contraindications to contact-
ing the family by asking, “Can you think of any reason why 
it would not be appropriate to contact this family later this 
year?”
Prior to the parent call, a second exclusion criterion is 
implemented when we use NBS laboratory tracking data to 
exclude parents of infants who had non-normal sweat test 
Project on Improvement of Communication Process and 
Outcomes after Newborn Screening (the Project). We adapted 
our methods from quality improvement techniques used for 
medical record review, simplified telephone follow-up, and 
patient tracking, so that the Project would be affordable and 
sustainable after research funding ended and replicable by other 
NBS programs without major budget increases.  Eventually, it 
is hoped that these types of methods may be useful for other 
genetic conditions, as well as for false-positive results of meta-
bolic screening tests.
The purpose of this paper is to describe the initial work-
ings of the Project, ranging from feasibility of identifying NBS 
results and PCPs, to preliminary findings from evaluation sur-
veys. 
METHODS
At its core, the Project is designed to be a quality improve-
ment effort by the NBS program of the Wisconsin State 
Laboratory of Hygiene and the Department of Health Services, 
with the Medical College of Wisconsin as a contracted agent. 
Methods and materials are approved by Institutional Review 
Boards at the Medical College of Wisconsin and University of 
Wisconsin–Madison.
Setting
When NBS identifies either CF or SCH, the NBS laboratory 
communicates by telephone with the infant’s PCP and sub-
specialists to facilitate identification, treatment, and follow-up. 
The NBS laboratory obtains PCP contact information from 
the birthing facility’s specimen collection card. Anecdotal expe-
rience shows that the clinician listed on the NBS card occa-
sionally is incorrect, and the baby’s full name may not be listed 
(eg, “Baby Boy Smith”). When the clinician’s name is not the 
PCP, the listed clinician often is expected to forward the results 
to the actual PCP or to take temporary responsibility for the 
infant. When the baby’s full name is incorrect, the clinician or 
the NBS laboratory must backtrack to the birthing facility to 
connect the result with the correct infant and PCP.
Usual practice is somewhat different when NBS identifies 
heterozygous carrier status for CF and SCH, which occurs in 
far greater numbers than results indicating true CF or SCH. 
SCH carrier results (defined by the presence of fetal, adult, 
and sickle hemoglobin, or “FAS”) are mailed to the PCP 
because these results are not medically urgent. Note that 
NBS also identifies carriers for other hemoglobinopathies (eg, 
Hemoglobin C, D, and E), but the Project is limited to hemo-
globin S to focus its analyses on the most common condition. 
CF carrier status in NBS is defined by a blood spot show-
ing an elevated immunoreactive trypsinogen and a single 
CF-associated mutation, followed by a normal sweat chloride 
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results (ie, results indicating the pres-
ence of CF).
Parents are offered a $20 gift certificate 
to more than 200 local or Internet mer-
chants as a gratuity for their participation.
Procedures
Protocol for locating PCPs. The Project’s 
first goal is to ensure that the NBS labo-
ratory report has reached the provider 
who has actual primary care responsibil-
ity for the infant. We begin by sending 
an introductory fax and a copy of the 
NBS result to the clinician listed by the 
birthing facility, using information from 
a directory maintained by the NBS labo-
ratory. A Project caller then telephones 
the clinician’s office and asks if the cli-
nician is the infant’s PCP. If the clini-
cian does not know the infant or denies 
a PCP relationship, the Project caller 
attempts to find the PCP by asking the 
clinician for advice, and then by contact-
ing the birthing facility or its medical 
record department. If these methods are 
not successful in finding the PCP, in a 
few days the Project team contacts the 
listed clinician again to see if the infant’s 
parents have  made an appointment. IRB 
stipulations disallow the Project team from contacting families 
directly.
When the Project caller reaches the PCP, he or she asks if 
the PCP has questions about the NBS result or its implications, 
and describes the Project goals and the parent call. If time 
allows, the Project caller invites the PCP to rehearse how he or 
she will inform the infant’s parent(s) about the result. Project 
callers exercise judgment in deferring the rehearsal invitation if 
the PCP is hurried due to being contacted between patients. 
When the PCP does agree to rehearse, that portion of the call 
is audiotaped, transcribed, and de-identified for future analysis.
Protocol for locating parents. If neither the NBS laboratory 
report nor the PCP identify a reason for exclusion, the parents 
are mailed an initial contact letter when the infant is about 3 
months old. The letter purposely does not mention the infant’s 
NBS result, in order to avoid confusion or distress for par-
ents who have not heard their child’s results or may not fully 
understand the implications of the results. Also included is a 
“decline of contact” card to give the parents an opportunity to 
decline participation without becoming fully informed about 
the Project.
Figure 1. Usual practice (left) and Project methods (right) after newborn screening identifies carrier 
status for sickle cell hemoglobinopathy or likely carrier status for cystic fibrosis.
Abbreviations = NBS, newborn screening; SCH, sickle cell hemoglobinopathy; CF, cystic fibrosis; PCP, 
the infant’s primary care provider.
aNot shown: for infants with the likely CF carrier result, the PCP orders a sweat chloride test to 
verify that CF is not present.
PCP informs parent about the resulta
NBS lab sends result to the PCP
NBS result abnormal (SCH carrier, or likely CF carrier status)
Over time, parents may…
 Access other sources of information
 Confuse or forget what they learn
 Develop psychosocial problems
PCP receives NBS result
NBS lab sends result to the Project team
Call #1. Project team contacts PCP
(ideally before the PCP informs parent)
Call #2. Project team contacts parent
(infant is between 2 and 5 mo. old)
Usual practice Project methods
Approximately 10 days after the initial contact letter is 
mailed, a Project caller telephones the parents. Parents are asked 
if they recall the letter and if they are willing to complete the 
call. They are given the opportunity to discontinue the phone 
call if it is an inconvenient time or if they simply are not inter-
ested. The Project caller follows a carefully designed script that 
weaves together components of informed consent, discussion 
about the screening result, open-ended survey questions, and 
fixed answer questions from established scales to assess psycho-
social outcomes such as parental anxiety and perceptions of the 
child’s health.15-18 
Project callers have a clinical background, so they have the 
expertise to perceive emotional distress or confusion over the 
phone. If serious distress or confusion becomes evident, the 
Project caller has the option of bypassing the research ques-
tions, transitioning to a purely clinical intervention. Regardless 
of whether a parent completes the entire call, the conversation 
ends with a debriefing effort to ensure there is no lingering 
confusion, and to provide assistance with self-referral to addi-
tional resources. 
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We were unable to identify a PCP for 50 infants with SCH 
carrier reports (6.1% of 817). In summary, using our contact 
procedures, we were able to identify PCPs for 767 infants, or 
93.9% of the 817 infants without exclusion criteria.
PCPs’ description of results communication. Of the 767 
infants for whom we identified and reached a PCP during the 
Project’s first 14 months, in 41 cases (5.4%) the PCP reported 
that he or she had not received the NBS result fax. For the 
other 672 infants, 130 PCPs reported already informing the 
parent in person (19.4%), 134 had already told the parent via 
telephone or planned to do so that day (19.9%), 377 planned 
to tell the parent at the next scheduled appointment (56.1%), 
3 planned to send a letter or an e-mail to the parent(s), and 16 
PCPs had not decided how to inform the parent. Only 3 PCPs 
planned to schedule a special appointment to discuss the NBS 
result.
PCPs were more likely to wait until the next appointment 
if the infant had an SCH carrier result than a likely CF carrier 
result (73% vs 43%, χ2, P < 0.001).
When we asked PCPs if they had questions about the NBS 
result or its implications, PCPs for 33 infants (4.9% of the 672) 
asked for an explanation. PCPs were more likely to request an 
explanation about likely CF carrier results than SCH carrier 
results (13.3% vs 3.0%, χ2, P < 0.001).
Many PCPs were willing to rehearse telling the infant’s 
parent(s). Of the 414 individual PCPs identified, we invited 
rehearsals from 196 PCPs (47.3%) who had not yet informed 
the parent(s). Of these, 118 agreed to rehearse (60.2%). Another 
42 PCPs (21.4%) indicated willingness to rehearse for another 
infant but deferred rehearsal for the current infant because of 
time limitations. There were no significant differences by PCP 
gender or clinical specialty with regard to availability for invita-
tion or agreement to rehearse.
The PCPs who rehearsed supplied some demographic infor-
mation. The average number of years since graduation from 
training was 16.7 (SD 10.4 years), with a maximum of 44 years. 
The average number of months since the PCP last discussed 
genetic carrier status with a patient was 12.8 (SD 24.7 months).
Project Acceptability by PCPs. By the end of the 14-month 
period analyzed for this paper, we received 79 anonymous 
evaluations from PCPs who rehearsed with us. We asked, 
“Was the information you obtained during the telephone 
call useful?” and gave them 3 options: “very useful” (27/79 
respondents), “somewhat useful” (44/79 respondents), and 
“not at all useful” (8/74 respondents). We asked: “Was the 
amount of time spent on the interview appropriate?” and gave 
them 3 options: “just right” (71/79 respondents), “too long,” 
(6/79 respondents), and “too short,” (0/79 respondents). Two 
left the response choices blank. As shown in Table 1, slightly 
Analysis
Both the PCP and parent calls are audio-recorded, transcribed, 
de-identified, and abstracted for quantitative data. Descriptive 
data, including the majority of data for this paper, are stored 
in a Microsoft Access database (Redmond, Washington) and 
analyzed using JMP software (SAS Institute, Cary, North 
Carolina). A separate series of papers will report analysis of psy-
chosocial data from the parent calls and communication data 
from the PCP calls following our communication quality indi-
cator approach. The communication quality indicators follow 
our previously published techniques for jargon usage,19,20 assess-
ments of understanding,21 organizing behaviors,22 communica-
tion about potential emotions,23 and inclusion of key content 
messages.24,25
RESULTS
During the Project’s first 14 months, the Project team received 
929 NBS results from the NBS laboratory; 709 showed SCH 
carrier status and 220 showed likely CF carrier status. In 141 of 
the 220 likely CF carrier results, the ΔF508 mutation was seen 
(64.1%), while the other 79 infants had 1 of 18 other muta-
tions from the 23 included on Wisconsin’s screening panel. 
Gender was evenly distributed (49.1% male).
Information included on the NBS laboratory report, gesta-
tion age and the presence of multiple conditions, was sufficient 
to exclude 112 infants (12.1%) without the need for a PCP call. 
The remaining 817 infants who constitute the main sample for 
this analysis were submitted by 70 different birthing facilities 
and 4 home births. The median number of results listed for a 
facility was 36 (SD 26.1). The facilities listed a total of 414 cli-
nicians for their infants. The highest number of infants logged 
for a single PCP was 13.
Information about PCPs
Accuracy of PCP listing provided by the birthing facility. 
For 58.8% of infants, the birthing facility listed the accurate 
PCP, and the NBS laboratory had accurate contact information 
(Figure 2). For 14.2% of infants, the birthing facility had 
listed a clinical partner of the correct PCP, so the NBS labora-
tory’s contact information was accurate even if the responsible 
PCP had not been listed. For the other 27% of infants, the 
information provided by the birthing facility was not sufficient 
for the NBS result to automatically reach the PCP. For 20.9% 
of the 817 infants, we found the PCP by following the protocol 
described in the Methods section. For 7.3% of the 817 infants, 
the birthing facility had provided the correct PCPs name, but 
the PCP had changed locations recently enough that the NBS 
report was faxed or mailed to an old address. PCPs of infants 
with likely CF carrier results were more likely to have moved 
than PCPs of infants with SCH carrier status (χ2, P = 0.03). 
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evaluate PCP explanations unfavorably if their health literacy 
was marginal or inadequate (χ2, P = 0.04).
Acceptability of the Project for the parents. By the end 
of the 14-month period, we received 70 anonymous parent 
evaluations. When asked: “Was the information you obtained 
during the telephone call useful?”, 50 replied “very useful” 
(71.4%) and 17 replied “somewhat useful” (24.3%). Three 
respondents said the information was “not at all useful” 
(4.3%). When asked: “Was the amount of time spent on the 
interview appropriate?”, 63 said that the time was “just right” 
(90%), and 7 said it was “too long” (10%). No one responded 
that the call was “too short.”
Time and Labor Involved
One of our main research questions at this point was the 
amount of time and labor needed to do follow-up on com-
munication processes and psychosocial outcomes in a typical 
sample of nearly 900 families per year. 
To facilitate planning for similar programs in the future, we 
tracked time and expenses for clinical and research aspects of 
the Project. Not counting IRB-required activities necessary for 
research, we estimate that telephone calls to PCPs and related 
administrative needs occupied half of each weekday for 1 staff 
person, or about 20 hours per week. Parent calls take longer, 
requiring almost 40 hours per week of staff time for calls and 
documentation. Because of the research and IRB needs for the 
Project, the call workload was spread out over several members 
of our lab’s team, including a genetic counselor, 3 nurses, a 
coordinator, and the project director (a pediatrician).
more than half of the PCPs reported that 
being notified about the NBS result or 
having the opportunity to rehearse had 
influenced their interaction with parents.
Parent Information
Of the 767 infants for whom we iden-
tified and reached a PCP, we were told 
of contraindications to us contacting the 
parents for a follow-up call in 54 cases 
(7%), including 29 infants whose fami-
lies did not speak English. Seventeen 
were excluded due to non-normal sweat 
test before the parent call. 
The outcomes of our attempts to 
reach the remaining 696 infants with 
SCH carrier results and likely CF carrier 
results are listed in Table 2. Overall, we 
were able to complete a call for 297 par-
ents, or 50.4% of eligible parents. The 
infants’ average age at the time of the 
call was 107.5 days old.
Most of the called parents were mothers, but 8 fathers 
(2.7%) were called.  The average age of parents called was 
26.7 years (SD 6.6). The youngest person we called was a 
14-year-old mother; the oldest was a 46-year-old mother. We 
asked most parents their ethnic background in an open-ended 
question; 54% reported African American, 37% Caucasian, 
4% Latino, and 5% reported a combination, such as African 
American and Latino.
Results of the 3-item health literacy screener identified 
25 parents with the potential for a significant limitation in 
health literacy (9%). Another 83 parents (29.9%) answered 
the screening questions with intermediate-range answers con-
sistent with occasional health literacy problems.
Parents’ description of communication with the PCPs. 
The parents of 38.5% of the SCH carrier infants did not recall 
an explanation from the PCP. All of the parents of likely CF 
carrier infants recalled an explanation except for one, despite 
that infant having gone through the sweat testing process, 
which includes meeting with a genetic counselor, prior to our 
phone call.
When asked how well the PCP had explained the result, 
48.5% of parents responded “well” or “very well.” Responses 
were similar to a question about general satisfaction with the 
NBS experience. Parents were more likely to be satisfied if 
they remembered an explanation or if they evaluated the PCP’s 
explanation favorably (χ2, P < 0.01). There was no apparent dif-
ference in satisfaction of parents of likely CF carrier infants 
versus SCH carrier infants, but parents were more likely to 
Figure 2. Accuracy of PCP information provided by the birthing facility for SCH (sickle cell hemo-
globinopathy)  and CF (cystic fibrosis) carrier infants
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Limitations
The Project methods are elaborate in 
order to integrate into usual-practice 
NBS, but some limitations are inevitable. 
Some selection bias may be present despite 
our response rate and status as a quality 
improvement project. Due to IRB restric-
tions and NBS legislative rules about con-
tacting parents directly, we have little or 
no reliable data about many of the parents 
who were not reachable via the 2 proto-
cols described earlier. In addition, the use 
of survey methods may be associated with 
the social desirability and Hawthorne 
effects, a change in participant behavior 
due to a sense of observation. Further 
study may be needed to know whether 
it is reasonable to generalize our findings 
about infants with carrier status for CF 
and SCH to other types of carrier states 
and to false positive NBS results.
CONCLUSION
To ensure that NBS and associated interventions consistently 
lead to more good than harm, clinicians need to assume 
responsibility and provide high-quality care for carrier and dis-
ease-affected infants. Future reports will comment on the psy-
chosocial data we have gathered which indicates that parents 
do experience real psychosocial effects of poor communication 
about NBS results. The role of communication quality assur-
ance and centralized follow-up will be to support PCPs and 
parents as they deal with positive and false-alarm NBS results. 
We further hope that the Project and forthcoming papers will 
serve as models for other population-scale efforts to improve 
the quality of communication in many other areas of health 
care.
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